Weekly Market Recap: November 29 – December 03

KEY DEVELOPENTS

Omicron variant was in the spotlight, as the United Sates reported their first case on Wednesday [1], while Moderna's CEO Stéphane Bancel had warned of likely lower vaccine efficacy earlier in the week. [2]

The spread of Omicron had led to a rethink of the heightened expectation around the Fed's tightening path, but this week we saw another barrage of hawkish commentary by central bank officials. Mr Powell was at the forefront, hinting at faster QE conclusion and also calling for a withdrawal of the term "transitory" in regards to inflation during his Senate testimony [3] – comments that were largely repeated a day later in the House of representatives.

The European Central bank on the other hand, continued to beat its dovish drum, with President Lagarde saying it is very unlikely that rates will rise in 2022, in the ReutersNext conference on Friday. [4]

On Thursday OPEC+ stack to its plan to add 0.4 million barrels of oil per day for the month of January 2022, while noting it is ready for adjustments passed on pandemic developments.

Trade the News: View our Economic Calendar

Over in Washington, the US Senate passed bill to fund government through February 18 and avert a shutdown. [5]

On the data front, Friday's US Jobs report was the main event, with the US economy adding only 210 jobs in November – in one more disappointing print. Unemployment rate dropped to 4.2%, from October's 4.6%.

Canada's employment figures were much better, with the creation of 153.7K jobs and Unemployment receding to 6%.

MARKET MOVEMENTS

The US Dollar was heading towards another profitable week, as the Fed's hawkish message resonated. NZD and AUD and GBP dropped to new 2021 lows against it, while EUR/USD was having an inconclusive week at the time of writing.

Stock markets in the US were facing difficulties at the time of writing, while GER30 was nearing towards a profitable close.

USOil was trying for profits, while XAU/USD was down.

CORPORATE ACTIVITY

This week had many news around proposed acquisitions, name changes and regulatory scrutiny.

WEEK AHEAD (GMT)

Next week focus will shift to the central banks of Australia (RBA) and Canada (BoC), as the will be handing down their monetary policy decisions, on Tuesday and Wednesday respectively. The RBA is on the dovish side as it still runs an asset purchase program and has pushed back against calls for faster tightening, whereas the bank of Canada concluded its QE in the previous policy meeting.

Market participants will also be looking forward to CPI Inflation figures for the US (Friday) and China (Thursday).

Nikos Tzabouras

Senior Market Specialist

Nikos Tzabouras is a graduate of the Department of International & European Economic Studies at the Athens University of Economics and Business. He has a long time presence at FXCM, as he joined the company in 2011. He has served from multiple positions, but specializes in financial market analysis and commentary.

With his educational background in international relations, he emphasizes not only on Technical Analysis but also in Fundamental Analysis and Geopolitics – which have been having increasing impact on financial markets. He has longtime experience in market analysis and as a host of educational trading courses via online and in-person sessions and conferences.

References

1

Retrieved 03 Dec 2021 https://www.cdc.gov/media/releases/2021/s1201-omicron-variant.html

2

Retrieved 03 Dec 2021 https://www.ft.com/content/27def1b9-b9c8-47a5-8e06-72e432e0838f

3

Retrieved 03 Dec 2021 https://www.c-span.org/video/

4

Retrieved 03 Dec 2021 https://twitter.com/Lagarde/status/1466686551786770433

5

Retrieved 23 Jan 2022 https://www.opec.org/opec_web/en/press_room/6736.htm

Disclosure

Any opinions, news, research, analyses, prices, other information, or links to third-party sites contained on this website are provided on an "as-is" basis, as general market commentary and do not constitute investment advice. The market commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is therefore not subject to any prohibition on dealing ahead of dissemination. Although this commentary is not produced by an independent source, FXCM takes all sufficient steps to eliminate or prevent any conflicts of interests arising out of the production and dissemination of this communication. The employees of FXCM commit to acting in the clients' best interests and represent their views without misleading, deceiving, or otherwise impairing the clients' ability to make informed investment decisions. For more information about the FXCM's internal organizational and administrative arrangements for the prevention of conflicts, please refer to the Firms' Managing Conflicts Policy. Please ensure that you read and understand our Full Disclaimer and Liability provision concerning the foregoing Information, which can be accessed here.

Past Performance: Past Performance is not an indicator of future results.

Risk Warning: Our service includes products that are traded on margin and carry a risk of losses in excess of your deposited funds. The products may not be suitable for all investors. Please ensure that you fully understand the risks involved.

${getInstrumentData.name} / ${getInstrumentData.ticker} /

Exchange: ${getInstrumentData.exchange}

${getInstrumentData.bid} ${getInstrumentData.divCcy} ${getInstrumentData.priceChange} (${getInstrumentData.percentChange}%) ${getInstrumentData.priceChange} (${getInstrumentData.percentChange}%)